GOSS earnings: real EPS beat/miss history, analyst consensus Buy, P/E -0.18. Updated 2026-07-23.
Gossamer Bio (GOSS) Research Hub
Gossamer Bio (GOSS) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 10.73 USD (+6618.85%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.18, market cap 0.03B. This hub links to the full technical, earnings and options research available for GOSS.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 10.73 USD (+6618.85%) |
| 52-week range | 0.127 USD – 12.52 USD |
| Trend regime | Range |
| 14-day RSI | 99.1 (Overbought) |
| Trailing P/E | -0.18 |
| Market cap | 0.03B |
| Dividend yield | 0.00% |
Available research for GOSS
Covered Call on GOSS: how it works, illustrative setup around the real 10.73 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on GOSS: how it works, illustrative setup around the real 10.73 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on GOSS: how it works, illustrative setup around the real 10.73 USD price, max profit/loss, breakeven and when to use it. Educational.
GOSS technical analysis: range, last 10.73 USD, RSI 99.1, 52w range 0.127 USD–12.52 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is GOSS in?
Gossamer Bio (GOSS) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is GOSS in an uptrend or downtrend?
As of 2026-09-11, GOSS is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is GOSS's trailing P/E ratio?
GOSS's trailing P/E is -0.18, with a market cap of 0.03B. See the earnings research page for full valuation detail.